Skip header and navigation

43 records – page 1 of 3.

Date Research Question / Title Unique ID Research Team
November 26, 2021 How effective are COVID-19 vaccines? INF031801v017 RR Infectious Disease
November 26, 2021 How effective are COVID-19 vaccines? INF031801v018 ESR Infectious Disease
November 12, 2021 How effective are COVID-19 vaccines? INF031801v017 ESR Infectious Disease
October 7, 2021 What is the current evidence and recommendations regarding COVID-19 vaccine booster shots (exceeding 2 doses) for the general population? EOC210902 RR EOC
September 29, 2021 What is the current evidence and recommendations regarding COVID-19 vaccine booster shots (exceeding 2 doses) for the general population? EOC210902 ESR EOC
July 16, 2021 What is known about safety/efficacy of global vaccines not approved in Canada? What are the impacts on international travel and vaccination policies? INF210701 ESR Infectious Disease
March 18, 2021 What are the differences between COVID-19 vaccines and how should they be distributed based on population group(s)? EOC031001 RR EOC
March 12, 2021 What are the vaccination strategies for vulnerable populations? PH030401 RR Public Health
March 11, 2021 What are the differences between COVID-19 vaccines and how should they be distributed based on population group(s)? EOC031001-01 ESR EOC
March 4, 2021 What are the vaccination strategies for vulnerable populations? PH030401-01 ESR Public Health
January 27, 2021 What is the risk of transmission of COVID-19 from high respiratory efforts for prolonged periods of time (>15 min) at a physical distance of 3-4 m or more? PH012501-02 ESR Public Health
January 26, 2021 What is the risk of transmission of COVID-19 from high respiratory efforts for prolonged periods of time (>15 min) at a physical distance of 3-4 m or more? PH012501-01 ESR Public Health
January 19, 2021 How are other jurisdictions distributing COVID-19 vaccines in non-healthcare worker environments and what is the rationale for those distribution models? PH011401 RR Public Health
January 15, 2021 How are other jurisdictions distributing COVID-19 vaccines in non-healthcare worker environments and what is the rationale for those distribution models? PH011401-01 ESR Public Health
January 11, 2021 What public health interventions are effective in reducing the burden of COVID-19 disease in comparable jurisdictions to Saskatchewan? PH111001 RR Public Health
December 18, 2020 What is the risk of COVID-19 transmission during AGMP procedures? PPE120901 RR Personal Protective Equipment
December 17, 2020 How is COVID-19 transmitted from person-to-person and what is the most common source of transmission? INF121501 RR Infectious Disease
December 15, 2020 How is COVID-19 transmitted from person-to-person and what is the most common source of transmission? INF121501-01 ESR Infectious Disease
December 11, 2020 What is the risk of COVID-19 transmission during AGMP procedures? PPE120901-01 ESR Personal Protective Equipment
December 1, 2020 What is the evidence for the effectiveness of universal mask use by the public? [Update] EOC062301v3-01 ESR EOC

43 records – page 1 of 3.